Literature DB >> 22042057

Cultured human mast cells are heterogeneous for expression of the high-affinity IgE receptor FcεRI.

Hans Jürgen Hoffmann1, Pernille Munk Frandsen, Lars Harder Christensen, Peter Oluf Schiøtz, Ronald Dahl.   

Abstract

OBJECTIVE: We determined the density of FcεRI on mast cells cultured from cord (CBMC) and peripheral blood (PBMC) and studied the kinetics of the response through FcεRI.
METHODS: Mast cells were cultured from CD133+ progenitors from peripheral or cord blood. FcεRI was stabilized by culture with 2 μg/ml IgE. Cells were activated by addition of anti-FcεRI antibody (1 ng/ml-10 μg/ml). Maximal activation, sensitivity, and cooperativity were determined.
RESULTS: All cultures were homogeneous for tryptase and metachromasy. All cells expressing FcεRI could be activated by cross-linking FcεRI to upregulate CD63. PBMC bind 203,000 molecules of IgE/cell. Stabilization of FcεRI with IgE doubled the number of CD63+ cells (p = 0.0001) and increased the sensitivity (from 0.083 to 0.013 μg/ml anti-FcεRI) and the slope factor (from 10.8 to 68) of PBMC but not of CBMC. Anti-IgE reversed these effects (p = 0.0002) but did not reduce activation levels below that of cell lines not stabilized with IgE.
CONCLUSION: Baseline expression of FcεRI is independent of anti-IgE. The fraction of PBMC that binds high levels of IgE can be activated through FcεRI.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22042057     DOI: 10.1159/000328756

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  5 in total

1.  Lin- CD34hi CD117int/hi FcεRI+ cells in human blood constitute a rare population of mast cell progenitors.

Authors:  Joakim S Dahlin; Andrei Malinovschi; Helena Öhrvik; Martin Sandelin; Christer Janson; Kjell Alving; Jenny Hallgren
Journal:  Blood       Date:  2015-12-01       Impact factor: 22.113

2.  Genotype-dependent effects of TGF-β1 on mast cell function: targeting the Stat5 pathway.

Authors:  Josephine Fernando; Travis W Faber; Nicholas A Pullen; Yves T Falanga; Elizabeth Motunrayo Kolawole; Carole A Oskeritzian; Brian O Barnstein; Geethani Bandara; Geqiang Li; Lawrence B Schwartz; Sarah Spiegel; David B Straus; Daniel H Conrad; Kevin D Bunting; John J Ryan
Journal:  J Immunol       Date:  2013-09-25       Impact factor: 5.422

3.  Increased IL-17RA and IL-17RC in End-Stage COPD and the Contribution to Mast Cell Secretion of FGF-2 and VEGF.

Authors:  Abraham B Roos; Michiko Mori; Harpreet K Gura; Axel Lorentz; Leif Bjermer; Hans Jürgen Hoffmann; Jonas S Erjefält; Martin R Stampfli
Journal:  Respir Res       Date:  2017-03-15

4.  Demonstration of human mast cell progenitors in the bone marrow.

Authors:  Maya Salomonsson; Johanna Ungerstedt; Perla A Alvarado-Vazquez; Jenny Hallgren
Journal:  Allergy       Date:  2019-08-27       Impact factor: 13.146

5.  Mast Cells in Skin Scarring: A Review of Animal and Human Research.

Authors:  Sara Ud-Din; Traci A Wilgus; Ardeshir Bayat
Journal:  Front Immunol       Date:  2020-09-30       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.